PTPRC and neoplasm: As shown in Figure 2A, the frequencies of tumor-infiltrating CD45+ leukocytes in tumor-bearing mice after virotherapy treatments were ∼4-fold higher compared with those in the untreated or sCXCR4-A-treated counterparts.